{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:19:27Z","timestamp":1770337167952,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1748-717x-9-124","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T11:04:41Z","timestamp":1401361481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma"],"prefix":"10.1186","volume":"9","author":[{"given":"Govin","family":"Thind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal","family":"Johal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Follwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagen Fritz","family":"Kennecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"issue":"1","key":"1095_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin 2014,64(1):9-29. 10.3322\/caac.21208","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1095_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/DCR.0b013e31819eb7f0","volume":"52","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A: Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the national cancer data base. Dis Colon Rectum 2009,52(4):624-631. 10.1007\/DCR.0b013e31819eb7f0","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"1095_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00001622-200007000-00011","volume":"12","author":"DP Ryan","year":"2000","unstructured":"Ryan DP, Mayer RJ: Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 2000,12(4):345-352. 10.1097\/00001622-200007000-00011","journal-title":"Curr Opin Oncol"},{"issue":"30","key":"1095_CR4","first-page":"089","volume":"20","author":"AB Moscicki","year":"2012","unstructured":"Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J: Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 2012,20(30):089.","journal-title":"Vaccine"},{"issue":"03","key":"1095_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0031-1286002","volume":"24","author":"J Poggio","year":"2011","unstructured":"Poggio J: Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal. Clin Colon Rectal Surg 2011,24(03):177-192. 10.1055\/s-0031-1286002","journal-title":"Clin Colon Rectal Surg"},{"issue":"6","key":"1095_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D: Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol 2013,14(6):516-524. 10.1016\/S1470-2045(13)70086-X","journal-title":"Lancet Oncol"},{"key":"1095_CR7","doi-asserted-by":"crossref","unstructured":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK co-ordinating committee on cancer research Lancet 1996,348(9034):1049-1054.","DOI":"10.1016\/S0140-6736(96)03409-5"},{"issue":"5","key":"1095_CR8","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol 1997,15(5):2040-2049.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1095_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jitlal M, Ledermann J: Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR anal cancer trial (ACT I). Br J Cancer 2010,102(7):1123-1128. 10.1038\/sj.bjc.6605605","journal-title":"Br J Cancer"},{"issue":"9","key":"1095_CR10","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996,14(9):2527-2539.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1095_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/0360-3016(91)90265-6","volume":"21","author":"BJ Cummings","year":"1991","unstructured":"Cummings BJ, Keane TJ, O\u2019Sullivan B, Wong CS, Catton CN: Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991,21(5):1115-1125. 10.1016\/0360-3016(91)90265-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1095_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1023\/A:1008295119573","volume":"8","author":"D Peiffert","year":"1997","unstructured":"Peiffert D, Seitz JF, Rougier P, Francois E, Cvitkovic F, Mirabel X, Nasca S, Ducreux M, Hannoun-Levi JM, Lusinchi A, Debrigode E, Conroy T, Pignon JP, Gerard JP: Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study. Ann Oncol 1997,8(6):575-581. 10.1023\/A:1008295119573","journal-title":"Ann Oncol"},{"issue":"4","key":"1095_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0360-3016(96)00146-0","volume":"35","author":"JA Martenson","year":"1996","unstructured":"Martenson JA, Lipsitz SR, Wagner H Jr, Kaplan EH, Otteman LA, Schuchter LM, Mansour EG, Talamonti MS, Benson AB 3rd: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an eastern cooperative oncology group study. Int J Radiat Oncol Biol Phys 1996,35(4):745-749. 10.1016\/0360-3016(96)00146-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"1095_CR14","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008,299(16):1914-1921. 10.1001\/jama.299.16.1914","journal-title":"JAMA"},{"issue":"35","key":"1095_CR15","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG: Long-term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol 2012,30(35):4344-4351. 10.1200\/JCO.2012.43.8085","journal-title":"J Clin Oncol"},{"key":"1095_CR16","doi-asserted-by":"crossref","unstructured":"Allegra CJ, Yothers G, O\u2019Connell MJ, Roh MS, Beart RW, Petrelli NJ, Lopa SH, Sharif S, Wolmark N: Neoadjuvant Therapy for Rectal Cancer: Mature Results from NSABP Protocol R-04, Abstract 390. J Clin Oncol 2014.,32(suppl 3; abstr 390):","DOI":"10.1200\/jco.2014.32.3_suppl.390"},{"issue":"suppl; abstr 35","key":"1095_CR17","first-page":"2011","volume":"29","author":"MS Roh","year":"2011","unstructured":"Roh MS, Yothers GA, O\u2019Connell MJ, Beart RW, Pitot HC, Shields AF, Parda DS, Sharif S, Allegra CJ, Petrelli NJ, Landry JC, Ryan DP, Arora A, Evans TL, Soori GS, Chu L, Landes RV, Mohiuddin M, Lopa S, Wolmark N: The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. J Clin Oncol 2011,29(suppl; abstr 3503):2011.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1095_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/annonc\/mdj041","volume":"17","author":"A De Paoli","year":"2006","unstructured":"De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, Pasetto L, Santantonio M, Sarti E, Mantello G, Innocente R, Frustaci S, Corv\u00f2 R, Rosso R: Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006,17(2):246-251.","journal-title":"Ann Oncol"},{"issue":"1","key":"1095_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","volume":"72","author":"R Glynne-Jones","year":"2008","unstructured":"Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D: EXTRA\u2013a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 2008,72(1):119-126. 10.1016\/j.ijrobp.2007.12.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1095_CR20","unstructured":"British Columbia Cancer Agency Protocol Summary for Curative Combined Modality Therapy for Carcinoma of the Anal Canal Using Mitomycin, Capecitabine and Radiation Therapy (GICART) 2013.http:\/\/www.bccancer.bc.ca\/NR\/rdonlyres\/C0A8933B-3AAD-4EBA-A95C-4552A0A060C9\/63672\/GICART_Protocol_1May2013.pdf . (Accessed May 30, 2013)"},{"key":"1095_CR21","unstructured":"British Columbia Cancer Agency Care of Radiation Skin Reactions 2012.http:\/\/www.bccancer.bc.ca\/NR\/rdonlyres\/79E81484-6809-41CF-8CC2-0646DA6003F8\/64011\/CareofRadiationSkinReactions.pdf (Accessed July 22, 2013)"},{"issue":"6","key":"1095_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1071\/SH12070","volume":"9","author":"AE Grulich","year":"2012","unstructured":"Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ: The epidemiology of anal cancer. Sex Health 2012,9(6):504-508. 10.1071\/SH12070","journal-title":"Sex Health"},{"issue":"No 15S (May 20","key":"1095_CR23","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1200\/jco.2009.27.15_suppl.4116","volume":"27","author":"C Eng","year":"2009","unstructured":"Eng C, Chang GJ, Das P, Rodriguez-Bigas MD, Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff AR, Crane CH: Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (xelox-xrt) for squamous cell carcinoma of the anal canal. J Clin Oncol 2009,27(No 15S (May 20 Supplement)):4116.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1095_CR24","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","volume":"29","author":"DG Haller","year":"2011","unstructured":"Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K, Schmoll HJ: Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011,29(11):1465-1471. 10.1200\/JCO.2010.33.6297","journal-title":"J Clin Oncol"},{"issue":"26","key":"1095_CR25","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1056\/NEJMoa043116","volume":"352","author":"C Twelves","year":"2005","unstructured":"Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kroning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schuller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W: Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005,352(26):2696-2704. 10.1056\/NEJMoa043116","journal-title":"N Engl J Med"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-9-124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:02:08Z","timestamp":1630555328000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-9-124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-9-124","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]},"assertion":[{"value":"29 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"124"}}